TY  - GEN
AB  - The FDA has received millions of reports of adverse events over the last ten years. A clinician's ability to identify potential drug-drug interactions in routine practice, even when aided by decision support software, is limited. To date, the literature does not report any attempts to use FDA Adverse Event Reporting System (AERS) data in clinical decision support systems. Data availability of data elements for patients and administrative information,  drug information, and diagnoses, reactions, and outcomes, varies widely.  The research question in this preliminary project is to determine if the data elements found in the FDA adverse event case reports were used and displayed by drug-drug interaction software, would that display be useful to clinicians in making prescribing or other therapeutic decisions?
AD  - Oregon Health and Science University
AU  - Enchin, Harry
DA  - 2011
DO  - 10.6083/M4X9288Z
DO  - DOI
ED  - Logan, Judith
ED  - Advisor
ID  - 580
KW  - Drug Interactions
KW  - Adverse Drug Reaction Reporting Systems
KW  - Decision Support Systems, Clinical
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Ototoxicity
KW  - Surveys and Questionnaires
KW  - Software
L1  - https://digitalcollections.ohsu.edu/record/580/files/581_etd.pdf
L2  - https://digitalcollections.ohsu.edu/record/580/files/581_etd.pdf
L4  - https://digitalcollections.ohsu.edu/record/580/files/581_etd.pdf
LK  - https://digitalcollections.ohsu.edu/record/580/files/581_etd.pdf
N2  - The FDA has received millions of reports of adverse events over the last ten years. A clinician's ability to identify potential drug-drug interactions in routine practice, even when aided by decision support software, is limited. To date, the literature does not report any attempts to use FDA Adverse Event Reporting System (AERS) data in clinical decision support systems. Data availability of data elements for patients and administrative information,  drug information, and diagnoses, reactions, and outcomes, varies widely.  The research question in this preliminary project is to determine if the data elements found in the FDA adverse event case reports were used and displayed by drug-drug interaction software, would that display be useful to clinicians in making prescribing or other therapeutic decisions?
PB  - Oregon Health and Science University
PY  - 2011
T1  - Adverse event reports: their role in detecting and preventing drug-drug interactions
TI  - Adverse event reports: their role in detecting and preventing drug-drug interactions
UR  - https://digitalcollections.ohsu.edu/record/580/files/581_etd.pdf
Y1  - 2011
ER  -